Skip to search formSkip to main contentSkip to account menu

2',3'-dideoxyguanosine

Known as: ddG (dideoxyguanosine) 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

2',3'-DideoxynucleosidesDideoxynucleosides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides (multidrug resistance/reverse…
A set of mutations (Ala-62 -> Val(A62V), V751, F77L, F116Y, and Q151M) in the polymerase domain of reverse transcriptase (RT) of… 
2011
2011
Simultaneous determination of metacavir and its metabolites in rat plasma using high-performance liquid chromatography with tandem mass spectrometric detection (LC-MS/MS).
A sensitive and selective liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous determination of… 
2003
2003
Initiation of phage 429 DNA replication in vitro : Formation of a covalent complex between the terminal protein , p 3 , and 5 '-dAMP ( protein-dAMP complex / 5 '-terminal protein / covalent linkage )
Incubation of extracts of +29-infected Bacillus subtilis with [a-32pl]dATP produced a labeled protein having the electrophoretic… 
2001
2001
Antiviral Guanosine Analogs as Substrates for Deoxyguanosine Kinase: Implications for Chemotherapy
ABSTRACT A highly active form of human recombinant deoxyguanosine kinase (dGK) phosphorylated purine nucleoside analogs active… 
1991
1991
Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosides.
A series of 6-substituted 2',3'-dideoxypurine ribofuranosides (ddP) was enzymatically synthesized with live E. coli in an effort… 
1991
1991
In vitro inhibition of hepatitis B virus replication by 2',3'-dideoxyguanosine, 2',3'-dideoxyinosine, and 3'-azido-2',3'-dideoxythymidine in 2.2.15 (PR) cells.
Hep G2-derived hepatoblastoma cells (2.2.15), which actively produce hepatitis B virus (HBV), were cultured in the presence of 2… 
1990
1990
Utilization of 2',3'-dideoxyguanosine 5'-triphosphate as an inhibitor and substrate for DNA polymerase alpha.
  • K. OnoH. Nakane
  • Biomedicine & pharmacotherapy = Biomedecine…
  • 1990
  • Corpus ID: 34811641
The activity of DNA polymerase alpha was strongly inhibited by low concentrations (less than 1 microM) of 2',3'-dideoxyguanosine… 
1986
1986
Inhibition du caractere infectieux et de l'effet cytopathique du htlv-iii/lav in vitro par la 2',3'-dideoxyinosine, 2',3'-dideoxyguanosine, ou 2',3'-dideoxyadenosine
Procede permettant d'adoucir les effets cytopathiques du virus HTLV-III sur des cellules, consistant a mettre en contact le virus… 
1984
1984
Analysis of bacteriophage phi X174 gene A protein-mediated termination and reinitiation of phi X DNA synthesis. I. Characterization of the termination and reinitiation reactions.
The phi X174 (phi X) gene A protein-mediated termination and reinitiation of single-stranded circular (SS(c] phi X viral DNA… 
1983
1983
Microtubule assembly with the guanosine 5'-diphosphate analogue 2',3'-dideoxyguanosine 5'-diphosphate.
The GDP analogue 2',2'-dideoxyguanosine 5'-diphosphate (ddGDP) supports efficient tubulin polymerization. Microtubule-associated… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)